Development of innovative oil-core self-organized nanovesicles prepared with chitosan and lecithin using a 2³ full-factorial design

References

• Cattani VB, Pohlmann AR, Dalla Costa T. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules. Int J Pharm 2008;363:214–216
   PubMed Web of Science ®Google Scholar
• Cattani VB, Fiel LA, Jager A, et al. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs. Eur J Pharm Sci 2010;39:116–124
   PubMed Web of Science ®Google Scholar
• Guterres SS, Fessi H, Barratt G, et al. Poly(d,l-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administration. Pharm Res 1995;12:1545–1547
   PubMed Web of Science ®Google Scholar
• Raffin RP, Obach E, Mezzalira G, et al. Nanocápsulas poliméricas secas contendo indometacina: estudo de formulação e tolerância gastrintestinal em ratos. Latin Am J Pharm 2003;22:163–172
   Google Scholar
• Haas SE, Bettoni CC, de Oliveira LK, et al. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo. Int J Antimicrob Agents 2009;34:156–161
   PubMed Web of Science ®Google Scholar
• Schaffazick SR, Siqueira IR, Badejo AS, et al. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm 2008;69:64–71
   PubMed Web of Science ®Google Scholar
• Bernardi A, Braganhol E, Jager E, et al. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Lett 2009;281:53–63
   PubMed Web of Science ®Google Scholar
• Cruz L, Schaffazick SR, Dalla Costa T, et al. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. J Nanosci Nanotechnol 2006;6:3154–3162
   PubMed Web of Science ®Google Scholar
• Cruz L, Soares LU, Costa TD, et al. Diffusion and mathematical modeling of release profiles from nanocarriers. Int J Pharm 2006;313:198–205
   PubMed Web of Science ®Google Scholar
• Cruz L, Assumpcao E, Andrade SF, et al. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats. Eur J Pharm Sci 2010;40:441–447
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. American Pharmacists Association. In: Rowe RC, Sheskey PJ, Quinn ME, ed. Handbook of pharmaceutical excipients. 6th ed. London: Chicago: APhA/Pharmaceutical Press; 2009. 917 p
   Google Scholar
• Bender EA, Adorne MD, Colome LM, et al. Hemocompatibility of poly(varepsilon-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm 2012;426:271–279
   PubMed Web of Science ®Google Scholar
• Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 2010;56:290–299
   PubMed Web of Science ®Google Scholar
• Siqueira NM, Contri RV, Paese K, et al. Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules. Skin Pharmacol Physiol 2011;24:166–174
   PubMed Web of Science ®Google Scholar
• Ranjan OP, Shavi GV, Nayak UY, et al. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation. Arch Pharm Res 2011;34:1919–1929
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007;24:2198–2206
   PubMed Web of Science ®Google Scholar
• Bautzova T, Rabiskova M, Beduneau A, et al. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis. Eur J Pharm Biopharm 2012;81:379–385
   PubMed Web of Science ®Google Scholar
• Kadiyala I, Loo Y, Roy K, et al. Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes. Eur J Pharm Sci 2010;39:103–109
   PubMed Web of Science ®Google Scholar
• Rabea EI, Badawy ME, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003;4:1457–1465
   PubMed Web of Science ®Google Scholar
• Qi L, Xu Z, Jiang X, et al. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 2004;339:2693–2700
   PubMed Web of Science ®Google Scholar
• Kojima K, Okamoto Y, Miyatake K, et al. Effects of chitin and chitosan on collagen synthesis in wound healing. J Vet Med Sci 2004;66:1595–1598
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011;42:445–451
   PubMed Web of Science ®Google Scholar
• Slutter B, Plapied L, Fievez V, et al. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Rel 2009;138:113–121
   PubMed Web of Science ®Google Scholar
• Saremi S, Atyabi F, Akhlaghi SP, et al. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Int J Nanomed 2011;6:119–128
   PubMed Web of Science ®Google Scholar
• Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 2010;58:1423–1430
   PubMed Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed 2011;6:765–774
   PubMed Web of Science ®Google Scholar
• Dodane V, Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999;182:21–32
   PubMed Web of Science ®Google Scholar
• Borges O, Cordeiro-da-Silva A, Romeijn SG, et al. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Contr Rel 2006;114:348–358
   PubMed Web of Science ®Google Scholar
• Kibbe AH. American Pharmaceutical Association. Handbook of pharmaceutical excipients, 3rd ed. Washington, DC; London, UK: American Pharmaceutical Association; Pharmaceutical Press; 2000
   Google Scholar
• Rupp C, Steckel H, Muller BW. Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. Int J Pharm 2010;395:272–280
   PubMed Web of Science ®Google Scholar
• Manconi M, Mura S, Manca ML, et al. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. Int J Pharm 2010;392:92–100
   PubMed Web of Science ®Google Scholar
• Iosio T, Voinovich D, Perissutti B, et al. Oral bioavailability of silymarin phytocomplex formulated as self-emulsifying pellets. Phytomedicine 2011;18:505–512
   PubMed Web of Science ®Google Scholar
• Colome LM, Raffin RP, Assumpcao E, et al. Theospheres based on Theobroma grandiflorum seed butter: development of innovative nanoparticles for skin aplication. Soft Materials 2010;8:72–88
   Web of Science ®Google Scholar
• Nornoo AO, Zheng H, Lopes LB, et al. Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies. Eur J Pharm Biopharm 2009;71:310–317
   PubMed Web of Science ®Google Scholar
• Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 2010;27:1469–1486
   PubMed Web of Science ®Google Scholar
• Sonvico F, Cagnani A, Rossi A, et al. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int J Pharm 2006;324:67–73
   PubMed Web of Science ®Google Scholar
• Tan Q, Liu W, Guo C, Zhai G. Preparation and evaluation of quercetin-loaded lecithin--chitosan nanoparticles for topical delivery. Int J Nanomed 2011;6:1621–1630
   PubMed Web of Science ®Google Scholar
• Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm 2009;381:205–213
   PubMed Web of Science ®Google Scholar
• Hafner A, Durrigl M, Pepic I, Filipovic-Grcic J. Short- and long-term stability of lyophilised melatonin-loaded lecithin/chitosan nanoparticles. Chem Pharm Bull (Tokyo) 2011;59:1117–1123
   PubMed Web of Science ®Google Scholar
• Senyigit T, Sonvico F, Barbieri S, et al. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Contr Rel 2010;142:368–373
   PubMed Web of Science ®Google Scholar
• Changez M, Varshney M, Chander J, Dinda AK. Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Colloids Surf B Biointerfaces 2006;50:18–25
   PubMed Web of Science ®Google Scholar
• Liu H, Wang Y, Lang Y, et al. Bicontinuous cyclosporin a loaded water-AOT/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo. J Pharm Sci 2009;98:1167–1176
   PubMed Web of Science ®Google Scholar
• Chadha R, Gupta S, Pathak N. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Drug Dev Ind Pharm 2012;38:1538–1546
   PubMed Web of Science ®Google Scholar
• Zidan AS, Sammour OA, Hammad MA, et al. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box--Behnken design and desirability function. Int J Pharm 2007;332:55–63
   PubMed Web of Science ®Google Scholar
• Poletto FS, Silveira RP, Fiel LA, et al. Size-control of poly(epsilon-caprolactone) nanospheres by the interface effect of ethanol on the primary emulsion droplets. J Nanosci Nanotechnol 2009;9:4933–4941
   PubMedGoogle Scholar
• Shah M, Pathak K. Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design. AAPS PharmSciTech 2010;11:489–496
   PubMed Web of Science ®Google Scholar
• Guterres SS, Weiss V, de Lucca Freitas L, Pohlmann AR. Influence of benzyl benzoate as oil core on the physicochemical properties of spray-dried powders from polymeric nanocapsules containing indomethacin. Drug Deliv 2000;7:195–199
   PubMed Web of Science ®Google Scholar
• Haas SE, Brum Junior L, de Andrade C, et al. Highly sensitive LC-MS/MS method for the determination of clozapine in rat plasma: application to a preclinical pharmacokinetic study. J Liq Chromatogr Rel Technol 2012;35:2873–2883
   Web of Science ®Google Scholar
• Rowland M, Tozer T, ed. Clinical pharmacokinetics: concepts and applications. Philadelphia, PA: Lea & Febiger; 1995
   Google Scholar
• Gerelli Y, Barbieri S, Di Bari MT, et al. Structure of self-organized multilayer nanoparticles for drug delivery. Langmuir 2008;24:11378–11384
   PubMedGoogle Scholar
• Venturini CG, Jager E, Oliveira CP, et al. Formulation of lipid core nanocapsules. Coll Surf A: physicochem Eng Aspects 2011;375:200–208
   Web of Science ®Google Scholar
• Pierre MB, Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res 2011;303:607–621
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 2012;8:489–496
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24:1–16
   PubMed Web of Science ®Google Scholar
• Chuah AM, Kuroiwa T, Ichikawa S, et al. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin. J Food Sci 2009;74:N1-N8
   PubMed Web of Science ®Google Scholar
• Grenha A, Gomes ME, Rodrigues M, et al. Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res A 2010;92:1265–1272
   PubMed Web of Science ®Google Scholar
• Mura P, Zerrouk N, Mennini N, et al. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur J Pharm Sci 2003;19:67–75
   PubMed Web of Science ®Google Scholar
• Singh S, Dobhal AK, Jain A, et al. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull (Tokyo) 2010;58:650–655
   PubMed Web of Science ®Google Scholar
• Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004;12:635–641
   PubMed Web of Science ®Google Scholar
• Zeng P, Xu Y, Zeng C, et al. Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int J Pharm 2011;415:259–266
   PubMed Web of Science ®Google Scholar
• Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201–230
   PubMed Web of Science ®Google Scholar
• Desbrieres J. Viscosity of semiflexible chitosan solutions: influence of concentration, temperature, and role of intermolecular interactions. Biomacromolecules 2002;3:342–349
   PubMed Web of Science ®Google Scholar
• Blasi P, Schoubben A, Romano GV, et al. Lipid nanoparticles for brain targeting II. Technological characterization. Colloids Surf B Biointerfaces 2013;110:130–137
   PubMed Web of Science ®Google Scholar
• Paramita V, Furuta T, Yoshii H. High-oil-load encapsulation of medium-chain triglycerides and D-limonene mixture in modified starch by spray drying. J Food Sci 2012;77:E38–E44
   Web of Science ®Google Scholar
• Mengual O, Meunier G, Cayre I, et al. TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis. Talanta 1999;50:445–456
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, et al. Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B Biointerfaces 2009;72:155–160
   PubMed Web of Science ®Google Scholar
• Brayden DJ, Baird AW. Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery. Adv Drug Deliv Rev 2004;56:721–726
   PubMed Web of Science ®Google Scholar
• Brayden DJ. Oral vaccination in man using antigens in particles: current status. Eur J Pharm Sci 2001;14:183–189
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6:231–248
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Aminabhavi TM. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J Contr Rel 2004;96:245–259
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Contr Rel 2005;107:215–228
   PubMed Web of Science ®Google Scholar